Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
暂无分享,去创建一个
[1] J. Bousquet,et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.
[2] C. Bachert,et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. , 2013, The Journal of allergy and clinical immunology.
[3] Yong‐jun Liu,et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells , 2007, The Journal of experimental medicine.
[4] E. Hickman,et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. , 2009, The Journal of clinical investigation.
[5] C. Akdis,et al. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors , 2008, Allergy.
[6] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[7] P. Hellings,et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. , 2003, American journal of respiratory cell and molecular biology.
[8] C. Akdis,et al. Therapeutic manipulation of immune tolerance in allergic disease , 2009, Nature Reviews Drug Discovery.
[9] J. Lötvall,et al. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. , 2005, American journal of respiratory cell and molecular biology.
[10] C. Akdis,et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. , 2000, The Journal of clinical investigation.
[11] Reto Crameri,et al. Novel vaccines and adjuvants for allergen-specific immunotherapy. , 2006, Current opinion in immunology.
[12] D. Meyers,et al. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. , 1982, Journal of Allergy and Clinical Immunology.
[13] M. Calderón,et al. Efficacy of allergen-specific immunotherapy for patients with atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.
[14] Choon-Sik Park,et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. , 2005, American journal of respiratory cell and molecular biology.
[15] M. Torrero,et al. Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. , 2015, The Journal of allergy and clinical immunology.
[16] B. Eberlein-König,et al. Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization * , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] N. York,et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study. , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] M. Karlsson,et al. Allergen-responsive CD4+CD25+ Regulatory T Cells in Children who Have Outgrown Cow's Milk Allergy , 2004, The Journal of experimental medicine.
[19] L. Håkansson,et al. Basophil Interleukin 4 and Interleukin 13 Production Is Suppressed during the Early Phase of Rush Immunotherapy , 2006, International Archives of Allergy and Immunology.
[20] C. Akdis,et al. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. , 2014, The Journal of clinical investigation.
[21] R. Valenta,et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy , 2015, The Journal of allergy and clinical immunology.
[22] C. Akdis,et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. , 1996, The Journal of clinical investigation.
[23] C. Akdis,et al. Regulation of TH17 and regulatory T cells in patients with Behçet disease. , 2011, The Journal of allergy and clinical immunology.
[24] P. Wallace,et al. Association between CD4(+)CD25(high) T cells and atopy in children. , 2007, The Journal of allergy and clinical immunology.
[25] A. Burks,et al. State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous. , 2014, The Journal of allergy and clinical immunology.
[26] B. Kirkham,et al. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. , 2002, Arthritis and rheumatism.
[27] S. Durham,et al. Mechanisms of immunotherapy. , 2004, The Journal of allergy and clinical immunology.
[28] S. Szabo,et al. Development of Spontaneous Airway Changes Consistent with Human Asthma in Mice Lacking T-bet , 2002, Science.
[29] C. Akdis,et al. MicroRNAs: Essential players in the regulation of inflammation. , 2013, The Journal of allergy and clinical immunology.
[30] C. Akdis,et al. Impact of systemic immuno‐suppression after solid organ transplantation on allergen‐specific responses , 2011, Allergy.
[31] E. Gelfand,et al. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. , 2010, The Journal of allergy and clinical immunology.
[32] C. Akdis,et al. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. , 2002, The Journal of allergy and clinical immunology.
[33] C. Akdis,et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.
[34] C. Akdis,et al. Differentiation and functional analysis of human T(H)17 cells. , 2009, The Journal of allergy and clinical immunology.
[35] Y. Belkaid,et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.
[36] Y. Ohya,et al. Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects. , 2007, The Journal of allergy and clinical immunology.
[37] Franz König,et al. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. , 2005, The Journal of allergy and clinical immunology.
[38] C. Akdis,et al. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy. , 2008, The Journal of allergy and clinical immunology.
[39] P. Parren,et al. Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.
[40] P. Patel,et al. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. , 2013, The Journal of allergy and clinical immunology.
[41] S. Durham,et al. Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.
[42] T. Casale,et al. Immunotherapy: what lies beyond. , 2014, The Journal of allergy and clinical immunology.
[43] S. Ying,et al. Fel d 1‐derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon‐γ+ T helper type 1 cells to sites of allergen‐induced late‐phase skin reactions in cat‐allergic subjects , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[44] C. Akdis,et al. T‐cell and antibody responses to phospholipase A2 from different species show distinct cross‐reactivity patterns , 2011, Allergy.
[45] G. Ogg,et al. Tracking Antigen-Specific T-Cells during Clinical Tolerance Induction in Humans , 2010, PloS one.
[46] S. Durham,et al. Mechanisms of immunotherapy: IgG revisited , 2004, Current opinion in allergy and clinical immunology.
[47] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[48] C. Akdis,et al. Histamine, histamine receptors and their role in immune pathology , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[49] C. Akdis,et al. Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells , 2004, The Journal of experimental medicine.
[50] F. Annunziato,et al. The 3 major types of innate and adaptive cell-mediated effector immunity. , 2015, The Journal of allergy and clinical immunology.
[51] C. Akdis,et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.
[52] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[53] F. Simons,et al. Histamine receptors are hot in immunopharmacology. , 2006, European journal of pharmacology.
[54] C. Akdis,et al. Immunological mechanisms of allergen‐specific immunotherapy , 2011, Allergy.
[55] I. Choi,et al. Mechanism for acute oral desensitization to antibiotics , 2006, Allergy.
[56] M. Okano,et al. Regulation and characterization of IL-17A expression in patients with chronic rhinosinusitis and its relationship with eosinophilic inflammation. , 2010, The Journal of allergy and clinical immunology.
[57] J. Schroeder,et al. Suppression of the immunologic response to peanut during immunotherapy is often transient. , 2015, The Journal of allergy and clinical immunology.
[58] J. Lidholm,et al. Component resolution reveals additional major allergens in patients with honeybee venom allergy. , 2014, The Journal of allergy and clinical immunology.
[59] P. Sly,et al. Prophylactic use of sublingual allergen immunotherapy in high-risk children: a pilot study. , 2013, The Journal of allergy and clinical immunology.
[60] L. Cosmi,et al. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. , 2007, The Journal of allergy and clinical immunology.
[61] C. Akdis,et al. IL‐33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma , 2011, European journal of immunology.
[62] T. Bieber,et al. Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. , 2010, The Journal of allergy and clinical immunology.
[63] C. Akdis,et al. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine , 2014, Allergy.
[64] Pilar Martín,et al. The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity. , 2010, The Journal of allergy and clinical immunology.
[65] Christoph Wilhelm,et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.
[66] T. Puhakka,et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. , 2012, The Journal of allergy and clinical immunology.
[67] C. Akdis,et al. In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure , 2008, The Journal of experimental medicine.
[68] C. Akdis. Allergy and hypersensitivity: mechanisms of allergic disease. , 2006, Current opinion in immunology.
[69] Y. Belkaid,et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid , 2007, The Journal of experimental medicine.
[70] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[71] C. Akdis,et al. Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell-mediated skin inflammation. , 2011, The Journal of allergy and clinical immunology.
[72] C. Akdis,et al. In utero priming by worms protects against respiratory allergies. , 2014, The Journal of allergy and clinical immunology.
[73] C. Akdis,et al. TNF-like weak inducer of apoptosis (TWEAK) and TNF-α cooperate in the induction of keratinocyte apoptosis. , 2011, The Journal of allergy and clinical immunology.
[74] M. Kurrer,et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17 , 2006, The Journal of experimental medicine.
[75] F Kauffmann,et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine , 2011, Allergy.
[76] S. Durham,et al. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. , 2014, The Journal of allergy and clinical immunology.
[77] C. Akdis,et al. Regulation of the immune response and inflammation by histamine and histamine receptors. , 2011, The Journal of allergy and clinical immunology.
[78] C. Akdis. Therapies for allergic inflammation: refining strategies to induce tolerance , 2012, Nature Medicine.
[79] O. Günther. [Immune tolerance]. , 1966, Medizinische Monatsschrift.
[80] C. Akdis,et al. The many routes of dendritic cells to ensure immune regulation. , 2011, The Journal of allergy and clinical immunology.
[81] G. Gleich,et al. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. , 1982, The Journal of allergy and clinical immunology.
[82] D. Umetsu,et al. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen , 2001, Nature Immunology.
[83] Q. Hamid,et al. Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.
[84] M. Akdiş,et al. NK cell subsets and their role in allergy , 2011, Expert opinion on biological therapy.
[85] C. Akdis,et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.
[86] C. Akdis,et al. Mechanisms of allergen-specific immunotherapy , 2012, Clinical and Translational Allergy.
[87] C. Akdis,et al. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. , 2007, The Journal of allergy and clinical immunology.
[88] C. Akdis,et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. , 2014, The Journal of allergy and clinical immunology.
[89] L. Borish,et al. Update on Allergy Immunotherapy , 2005, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.
[90] C. Akdis,et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells , 2009, The Journal of experimental medicine.
[91] H. Kita,et al. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. , 2014, The Journal of allergy and clinical immunology.
[92] N. Papadopoulos,et al. A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy. , 2013, The Journal of allergy and clinical immunology.
[93] C. Akdis,et al. Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. , 2011, The Journal of allergy and clinical immunology.
[94] Stacie M Jones,et al. Sustained Unresponsiveness to Peanut in Subjects Who Have Completed Peanut Oral Immunotherapy , 2014, Pediatrics.
[95] H. Dickensheets,et al. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. , 1999, Blood.
[96] C. Akdis,et al. Scientific foundations of allergen-specific immunotherapy for allergic disease. , 2014, Chest.
[97] C. Akdis,et al. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. , 2014, The Journal of allergy and clinical immunology.
[98] M. Rothenberg,et al. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. , 2013, The Journal of allergy and clinical immunology.
[99] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[100] Sergio Romagnani,et al. Immunologic influences on allergy and the TH1/TH2 balance. , 2004, The Journal of allergy and clinical immunology.
[101] A. Roberts,et al. Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.
[102] C. Akdis,et al. Update in the Mechanisms of Allergen-Specific Immunotheraphy , 2010, Allergy, asthma & immunology research.
[103] R. Dahl,et al. Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy. , 2014, The Journal of allergy and clinical immunology.
[104] M. Ravid,et al. A Six-Year Follow-up Study , 2016 .
[105] C. Akdis,et al. Mechanisms of immunotherapy to wasp and bee venom , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[106] S. Durham,et al. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. , 2014, Journal of Allergy and Clinical Immunology.
[107] R. Ree,et al. Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[108] H. Dickensheets,et al. Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .
[109] M. Dallman,et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease , 2004, The Lancet.
[110] Anita B. Roberts,et al. REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .
[111] L. Klimek,et al. Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: a pilot study. , 2014, The Journal of allergy and clinical immunology.
[112] C. Akdis,et al. A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[113] V. Kuchroo,et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells , 2008, Nature Immunology.
[114] M. Jutel,et al. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[115] M. Neurath,et al. Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells1 , 2004, The Journal of Immunology.
[116] R. D. Hatton,et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.
[117] T. Puhakka,et al. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood. , 2013, The Journal of allergy and clinical immunology.
[118] D. Barber,et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. , 2014, The Journal of allergy and clinical immunology.
[119] H. Hammad,et al. Essential Role of Lung Plasmacytoid Dendritic Cells in Preventing Asthmatic Reactions to Harmless Inhaled Antigen , 2004, The Journal of experimental medicine.
[120] Erkka Valovirta,et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). , 2002, The Journal of allergy and clinical immunology.
[121] M. Akdiş. Healthy immune response to allergens: T regulatory cells and more. , 2006, Current opinion in immunology.
[122] C. Akdis,et al. T-cell Subset Regulation in Atopy , 2011, Current allergy and asthma reports.
[123] M. Bachmann,et al. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy , 2009, The Journal of experimental medicine.
[124] J. Bousquet,et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. , 2013, The Journal of allergy and clinical immunology.
[125] B. Harder,et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[126] F. Spertini,et al. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. , 2014, The Journal of allergy and clinical immunology.
[127] Scott R. Presnell,et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.
[128] D. Gray,et al. Prevention of Arthritis by Interleukin 10–producing B Cells , 2003, The Journal of experimental medicine.
[129] C. Akdis,et al. Mechanisms of subcutaneous allergen immunotherapy. , 2011, Immunology and allergy clinics of North America.
[130] angesichts der Corona-Pandemie,et al. UPDATE , 1973, The Lancet.
[131] Daniel M. Altmann,et al. Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression , 2009, The Journal of experimental medicine.
[132] W. Busse,et al. Development of cockroach immunotherapy by the Inner-City Asthma Consortium. , 2014, The Journal of allergy and clinical immunology.
[133] P. Matricardi,et al. Rhinitis , sinusitis , and upper airway disease The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever , 2022 .
[134] H. Kita,et al. IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.
[135] R. Jacobs,et al. Eosinophilic esophagitis treated with immunotherapy to dust mites. , 2013, The Journal of allergy and clinical immunology.
[136] S. Durham,et al. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. , 2003, The Journal of allergy and clinical immunology.
[137] Richard T. Lee,et al. The IL-33/ST2 pathway: therapeutic target and novel biomarker , 2008, Nature Reviews Drug Discovery.
[138] Adnan Custovic,et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. , 2011, The Journal of allergy and clinical immunology.
[139] R. D. Hatton,et al. Transforming growth factor-beta induces development of the T(H)17 lineage. , 2006, Nature.
[140] C. Akdis,et al. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. , 2009, The Journal of allergy and clinical immunology.
[141] S. Durham,et al. Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response. , 2015, The Journal of allergy and clinical immunology.
[142] M. Jutel,et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. , 2005, The Journal of allergy and clinical immunology.
[143] S. Durham,et al. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. , 2008, The Journal of allergy and clinical immunology.
[144] C. Akdis,et al. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. , 2008, The Journal of allergy and clinical immunology.
[145] Kenneth G. C. Smith,et al. Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.
[146] C. Akdis,et al. IL-10-overexpressing B cells regulate innate and adaptive immune responses. , 2015, The Journal of allergy and clinical immunology.
[147] C. Akdis,et al. Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[148] R. Aalberse,et al. IgG4 breaking the rules , 2002, Immunology.
[149] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[150] A. Helbling,et al. Predictive value of venom‐specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom , 1989, Allergy.
[151] A. Woodcock,et al. Current mite, cat, and dog allergen exposure, pet ownership, and sensitization to inhalant allergens in adults. , 2003, The Journal of allergy and clinical immunology.
[152] W. Shreffler,et al. T(H)2 adjuvants: implications for food allergy. , 2008, The Journal of allergy and clinical immunology.
[153] C. Akdis,et al. Regulation of T cells and cytokines by the interleukin‐10 (IL‐10)‐family cytokines IL‐19, IL‐20, IL‐22, IL‐24 andIL‐26 , 2006, European journal of immunology.
[154] E. Vizi,et al. Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[155] A. Todo-Bom,et al. FoxP3, GATA‐3 and T‐bet expression in elderly asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[156] Cezmi A Akdis,et al. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. , 2005, The Journal of allergy and clinical immunology.
[157] O. Tastan,et al. Distinct regulation of tonsillar immune response in virus infection , 2014, Allergy.
[158] C. Akdis,et al. Modulation of immune responses by immunotherapy in allergic diseases. , 2014, Current opinion in pharmacology.
[159] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[160] T. Kündig,et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. , 2009, The Journal of allergy and clinical immunology.
[161] C. Akdis,et al. Novel immunotherapy vaccine development , 2014, Current opinion in allergy and clinical immunology.
[162] A. Nel,et al. T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. , 2008, The Journal of allergy and clinical immunology.
[163] T. Casale,et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. , 2013, The Journal of allergy and clinical immunology.
[164] Marek Jutel,et al. IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy , 2003, European journal of immunology.
[165] C. Akdis,et al. IL-10 suppresses CD2-mediated T cell activation via SHP-1. , 2009, Molecular immunology.
[166] W. Hop,et al. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. , 2012, The Journal of allergy and clinical immunology.
[167] D. Nicolae,et al. Maternal asthma and microRNA regulation of soluble HLA-G in the airway. , 2013, Journal of Allergy and Clinical Immunology.
[168] C. Akdis,et al. Fighting allergies beyond symptoms: The European Declaration on Immunotherapy , 2011, European journal of immunology.
[169] C. Akdis,et al. Specific immunotherapy and turning off the T cell: how does it work? , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[170] B. Seed,et al. Immune deficiencies , infection , and systemic immune disorders Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules , 2009 .
[171] O. Kalayci,et al. The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma , 2011, Allergy.
[172] D. Gentile,et al. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. , 2014, The Journal of allergy and clinical immunology.
[173] T. Casale,et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. , 2013, The Journal of allergy and clinical immunology.
[174] Kuender D Yang,et al. Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus-specific immunotherapy. , 2014, The Journal of allergy and clinical immunology.
[175] H. Malling,et al. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? , 2013, The Journal of allergy and clinical immunology.
[176] D. Larenas-Linnemann,et al. Use of omalizumab to improve desensitization safety in allergen immunotherapy. , 2014, The Journal of allergy and clinical immunology.
[177] S. Durham,et al. Cell-free detection of allergen-IgE cross-linking with immobilized phase CD23: inhibition by blocking antibody responses after immunotherapy. , 2013, The Journal of allergy and clinical immunology.
[178] C. Akdis,et al. Immunological mechanisms of allergen-specific immunotherapy , 2006, Nature Reviews Immunology.
[179] K. Mills,et al. Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.
[180] T. Kündig,et al. Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy. , 2014, The Journal of allergy and clinical immunology.
[181] J. Bousquet,et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update , 2014, The World Allergy Organization journal.
[182] Lisa C. Zaba,et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. , 2009, The Journal of allergy and clinical immunology.
[183] T. Kündig,et al. Intralymphatic immunotherapy: time interval between injections is essential. , 2014, The Journal of allergy and clinical immunology.
[184] K. Rabe,et al. T cells and eosinophils in bronchial smooth muscle cell death in asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[185] T. Bieber,et al. Early markers for protective mechanisms during rush venom immunotherapy , 2010, Allergy.